MEDISSIMO : revenue, balance sheet and financial ratios

MEDISSIMO is a French company founded 25 years ago, specialized in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques. Based in POISSY (78300), this company of category PME shows in 2019 a revenue of 5.0 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - MEDISSIMO (SIREN 434856209)
Indicator 2023 2022 2021 2020 2019 2018 2017 2016
Revenue N/C N/C N/C N/C 5 016 968 € 5 043 055 € 5 379 254 € N/C
Net income 1 105 253 € 1 668 049 € 1 019 253 € 1 000 957 € 577 144 € -2 804 379 € -1 586 533 € -1 250 501 €
EBITDA N/C N/C N/C N/C 885 758 € 229 588 € 793 821 € N/C
Net margin N/C N/C N/C N/C 11.5% -55.6% -29.5% N/C

Revenue and income statement

In 2023, MEDISSIMO generates positive net income of 1.1 M€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.

Net income (2023) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

1 105 253 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 0%. This very low level reflects a solid financial structure, offering significant room for future investments or acquisitions. Financial autonomy (= Equity / Total assets x 100) reaches 34%. The balance between equity and debt is satisfactory.

Debt ratio (2023) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

0.0%

Financial autonomy (2023) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

33.748%

Asset age ratio (2023) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

23.5%

Solvency indicators evolution
MEDISSIMO

Sector positioning

Debt ratio
0.0 2023
2021
2022
2023
Q1: 0.0
Med: 5.57
Q3: 50.77
Excellent

In 2023, the debt ratio of MEDISSIMO (0.00) ranks in the bottom 25% of the sector, which is positive. This ratio measures the weight of debt relative to equity. A low ratio indicates a solid financial structure with little dependence on creditors.

Financial autonomy
33.75% 2023
2021
2022
2023
Q1: 13.47%
Med: 38.42%
Q3: 58.45%
Average +20 pts over 3 years

In 2023, the financial autonomy of MEDISSIMO (33.8%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Liquidity ratios

The liquidity ratio (= Current assets / Current liabilities) stands at 92.19. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.

Liquidity ratio (2023) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

92.192

Liquidity indicators evolution
MEDISSIMO

Sector positioning

Liquidity ratio
92.19 2023
2021
2022
2023
Q1: 133.58
Med: 205.53
Q3: 329.15
Watch

In 2023, the liquidity ratio of MEDISSIMO (92.19) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2023) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2023) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2023) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2023) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
MEDISSIMO

Positioning of MEDISSIMO in its sector

Comparison with sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Valuation estimate

Based on 124 transactions of similar company sales (all years), the value of MEDISSIMO is estimated at 907 982 € (range 345 584€ - 3 315 837€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2023
124 transactions
345k€ 907k€ 3315k€
907 982 € Range: 345 584€ - 3 315 837€
NAF 5 all-time

Valuation method used

Net Income Multiple
1 105 253 € × 0.8x = 907 983 €
Range: 345 585€ - 3 315 837€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 124 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de gros (commerce interentreprises) de produits pharmaceutiques)

Compare MEDISSIMO with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de gros (commerce interentreprises) de produits pharmaceutiques

Frequently asked questions about MEDISSIMO

What is the revenue of MEDISSIMO ?

The revenue of MEDISSIMO in 2019 is 5.0 M€.

Is MEDISSIMO profitable?

Yes, MEDISSIMO generated a net profit of 1.1 M€ in 2023.

Where is the headquarters of MEDISSIMO ?

The headquarters of MEDISSIMO is located in POISSY (78300), in the department Yvelines.

Where to find the tax return of MEDISSIMO ?

The tax return of MEDISSIMO is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does MEDISSIMO operate?

MEDISSIMO operates in the sector Commerce de gros (commerce interentreprises) de produits pharmaceutiques (NAF code 46.46Z). See the 'Sector positioning' section above to compare the company with its competitors.